{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T07:52:16Z","timestamp":1771055536142,"version":"3.50.1"},"update-to":[{"DOI":"10.1371\/journal.pntd.0005459","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2017,4,25]],"date-time":"2017-04-25T00:00:00Z","timestamp":1493078400000}}],"reference-count":60,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2017,4,6]],"date-time":"2017-04-06T00:00:00Z","timestamp":1491436800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Infectious Diseases Society of America (US)","award":["Medical Scholar"],"award-info":[{"award-number":["Medical Scholar"]}]},{"name":"Pritzker School of Medicine (US)","award":["Innovation Funding"],"award-info":[{"award-number":["Innovation Funding"]}]},{"name":"University of Chicago Center for Global Health","award":["Global Health Scholarship"],"award-info":[{"award-number":["Global Health Scholarship"]}]},{"DOI":"10.13039\/100007637","name":"COLCIENCIAS","doi-asserted-by":"crossref","award":["222-972-553501"],"award-info":[{"award-number":["222-972-553501"]}],"id":[{"id":"10.13039\/100007637","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100007637","name":"COLCIENCIAS","doi-asserted-by":"crossref","award":["2229-519-28930"],"award-info":[{"award-number":["2229-519-28930"]}],"id":[{"id":"10.13039\/100007637","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100007637","name":"COLCIENCIAS","doi-asserted-by":"crossref","award":["222-972-553501"],"award-info":[{"award-number":["222-972-553501"]}],"id":[{"id":"10.13039\/100007637","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100007637","name":"COLCIENCIAS","doi-asserted-by":"crossref","award":["222972553501"],"award-info":[{"award-number":["222972553501"]}],"id":[{"id":"10.13039\/100007637","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000133","name":"Agency for Healthcare Research and Quality","doi-asserted-by":"publisher","award":["R00HS022433"],"award-info":[{"award-number":["R00HS022433"]}],"id":[{"id":"10.13039\/100000133","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Central Society for Clinical and Translational Research","award":["Early Career Development Award"],"award-info":[{"award-number":["Early Career Development Award"]}]}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"DOI":"10.1371\/journal.pntd.0005459","type":"journal-article","created":{"date-parts":[[2017,4,6]],"date-time":"2017-04-06T18:49:35Z","timestamp":1491504575000},"page":"e0005459","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":17,"title":["Cost-effectiveness of meglumine antimoniate versus miltefosine caregiver DOT for the treatment of pediatric cutaneous leishmaniasis"],"prefix":"10.1371","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7547-5882","authenticated-orcid":true,"given":"Brandon A.","family":"Berger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra","family":"Cossio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nancy Gore","family":"Saravia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria del Mar","family":"Castro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergio","family":"Prada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allison H.","family":"Bartlett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mai T.","family":"Pho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2017,4,6]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"e35671","DOI":"10.1371\/journal.pone.0035671","article-title":"Leishmaniasis worldwide and global estimates of its incidence [Internet]","author":"J Alvar","year":"2012","journal-title":"PLoS ONE"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.cimid.2004.03.004","article-title":"Leishmaniasis: Current situation and new perspectives","volume":"27","author":"P Desjeux","year":"2004","journal-title":"Comp Immunol Microbiol Infect Dis"},{"key":"ref3","unstructured":"Pan American Health Organization. Leishmaniases: Epidemiological Report of the Americas [Internet]. Washington, D.C.; 2015. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.paho.org\/hq\/index.php?option=com_docman&task=doc_download&Itemid=270&gid=31142&lang=en\" xlink:type=\"simple\">www.paho.org\/hq\/index.php?option=com_docman&amp;task=doc_download&amp;Itemid=270&amp;gid=31142&amp;lang=en<\/ext-link>"},{"key":"ref4","unstructured":"Instituto Nacional de Salud. Sivigila [Internet]. 2014 [cited 10 Sep 2014]. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.ins.gov.co\/lineas-de-accion\/Subdireccion-Vigilancia\/sivigila\/Paginas\/sivigila.aspx\" xlink:type=\"simple\">http:\/\/www.ins.gov.co\/lineas-de-accion\/Subdireccion-Vigilancia\/sivigila\/Paginas\/sivigila.aspx<\/ext-link>"},{"key":"ref5","article-title":"Bolet\u00edn epidemiol\u00f3gico semanal n\u00famero 52 de 2015","year":"2015"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"359","DOI":"10.4269\/ajtmh.12-0784","article-title":"Clinical and epidemiologic profile of cutaneous leishmaniasis in Colombian children: Considerations for local treatment","volume":"89","author":"VM Blanco","year":"2013","journal-title":"Am J Trop Med Hyg"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1086\/510860","article-title":"Pharmacokinetics of antimony in children treated for leishmaniasis with meglumine antimoniate","volume":"195","author":"A Cruz","year":"2007","journal-title":"J Infect Dis"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"187","DOI":"10.4269\/ajtmh.2001.64.187","article-title":"Treatment failure in children in a randomized clinical trial with 10 and 20 days of meglumine antimonate for cutaneous leishmaniasis due to Leishmania Viannia species","volume":"64","author":"R Palacios","year":"2001","journal-title":"Am J Trop Med Hyg"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.actatropica.2011.02.007","article-title":"Systematic review of the adverse effects of cutaneous leishmaniasis treatment in the New World [Internet]","author":"LF Oliveira","year":"2011","journal-title":"Acta Tropica"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1093\/infdis\/jir816","article-title":"Noninferiority of miltefosine versus meglumine antimoniate for cutaneous leishmaniasis in children","volume":"205","author":"LC Rubiano","year":"2012","journal-title":"J Infect Dis"},{"key":"ref11","first-page":"CD003343","article-title":"Directly observed therapy for treating tuberculosis","volume":"5","author":"J Karumbi","year":"2015","journal-title":"Cochrane database Syst Rev. Wiley-Blackwell"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1590\/S0102-311X2011000500012","article-title":"Cost-effectiveness of community health worker versus home-based guardians for directly observed treatment of tuberculosis in Vit\u00f3ria, Esp\u00edrito Santo State, Brazil","volume":"27","author":"TN do Prado","year":"2011","journal-title":"Cad Saude Publica"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1007\/s10900-009-9174-4","article-title":"A classification and meta-analysis of community-based directly observed therapy programs for tuberculosis treatment in developing countries","volume":"34","author":"S Kangovi","year":"2009","journal-title":"J Community Health"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/S0035-9203(99)90379-6","article-title":"Randomized controlled trial of directly observed treatment (DOT) for patients with pulmonary tuberculosis in Thailand","volume":"93","author":"P Kamolratanakul","year":"1999","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1111\/j.1365-3156.2004.01230.x","article-title":"Direct observation of treatment for tuberculosis: A randomized controlled trial of community health workers versus family members","volume":"9","author":"J Wright","year":"2004","journal-title":"Trop Med Int Heal"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1590\/S1020-49892012000900002","article-title":"Costo-efectividad de un tratamiento antituberculoso alternativo: seguimiento a convivientes residenciales de los pacientes. (Spanish)","volume":"32","author":"E Nieto","year":"2012","journal-title":"Rev Panam Salud P\u00fablica"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"e0148488","DOI":"10.1371\/journal.pone.0148488","article-title":"Direct observation of treatment provided by a family member as compared to non-family member among children with new tuberculosis: A pragmatic, non-inferiority, cluster-randomized trial in Gujarat, India","volume":"11","author":"PV Dave","year":"2016","journal-title":"PLoS One"},{"key":"ref18","unstructured":"Registros del Sistema de Vigilancia en Salud P\u00fablica. Municipio de Tumaco. Unpublished Data.; 2012."},{"key":"ref19","unstructured":"Registros del Sistema de Vigilancia en Salud P\u00fablica. Municipio de Chaparral. Unpublished Data.; 2003."},{"key":"ref20","unstructured":"Registros del Sistema de Vigilancia en Salud P\u00fablica. Municipio de Buenaventura. Unpublished Data.; 2015."},{"key":"ref21","first-page":"1","article-title":"Global distribution maps of the Leishmaniases","volume":"2014","author":"D. M. Pigott","year":"2014","journal-title":"Elife"},{"key":"ref22","doi-asserted-by":"crossref","DOI":"10.1093\/oso\/9780198529446.001.0001","article-title":"Methods for the Economic Evaluation of Health Care Programmes","author":"MF Drummond","year":"2005"},{"key":"ref23","unstructured":"Banco de la Republica de Colombia. Tasas de cambio monedas del mundo\u2014Cualquier pa\u00eds [Internet]. Jan 2016 [cited 18 Jan 2016]. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/obiee.banrep.gov.co\/analytics\/saw.dll?Go&_scid=JZQ*QgZMAqc\" xlink:type=\"simple\">http:\/\/obiee.banrep.gov.co\/analytics\/saw.dll?Go&amp;_scid=JZQ*QgZMAqc<\/ext-link>"},{"key":"ref24","unstructured":"Instituto Colombiano de Bienestar Familiar, Instituto Nacional de Salud, Ministerio de la Protecci\u00f3n Social, Asociaci\u00f3n Probienestar de la Familia Colombiana (Profamilia). Encuesta nacional de la situaci\u00f3n nutricional en Colombia 2010. Bogot\u00e1, D.C.; 2011."},{"key":"ref25","unstructured":"OPS. Leishmaniasis en las Americas: recomendaciones para el tratamiento. Washington, D.C.; 2013."},{"key":"ref26","unstructured":"Ministerio de la Protecci\u00f3n Social, Salud IN de S. Gu\u00eda para la atenci\u00f3n cl\u00ednica integral del paciente con leishmaniasis [Internet]. Bogot\u00e1, Colombia; 2010. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.ins.gov.co%252Ftemas-de-interes%252FLeishmaniasis%252520viceral%252F02%252520Clinica%252520Leishmaniasis.pdf\" xlink:type=\"simple\">www.ins.gov.co%252Ftemas-de-interes%252FLeishmaniasis%252520viceral%252F02%252520Clinica%252520Leishmaniasis.pdf<\/ext-link>"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pntd.0000912","article-title":"Miltefosine in the treatment of cutaneous leishmaniasis caused by leishmania braziliensis in Brazil: A randomized and controlled trial","volume":"4","author":"PR Machado","year":"2010","journal-title":"PLoS Negl Trop Dis"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"255","DOI":"10.4269\/ajtmh.2011.10-0155","article-title":"Randomized controlled clinical trial to access efficacy and safety of miltefosine in the treatment of cutaneous leishmaniasis caused by Leishmania (Viannia) guyanensis in Manaus, Brazil","volume":"84","author":"A Chrusciak-Talhari","year":"2011","journal-title":"Am J Trop Med Hyg"},{"key":"ref29","unstructured":"DCTD, NCI, NIH, DHHS. Cancer Therapy Evaluation Program, Common Terminology Criteria for Adverse Events, Version 3.0. In: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/ctep.cancer.gov\" xlink:type=\"simple\">http:\/\/ctep.cancer.gov<\/ext-link> [Internet]. 2003. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/ctep.cancer.gov\/\" xlink:type=\"simple\">http:\/\/ctep.cancer.gov\/<\/ext-link>"},{"key":"ref30","unstructured":"Control of the leishmaniases: Report of a meeting of the WHO Expert Committee on the Control of Leishmaniases [Internet]. Geneva, Switzerland; 2010 Mar. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/whqlibdoc.who.int\/trs\/WHO_TRS_949_eng.pdf\" xlink:type=\"simple\">http:\/\/whqlibdoc.who.int\/trs\/WHO_TRS_949_eng.pdf<\/ext-link>"},{"key":"ref31","unstructured":"WHO-CHOICE unit cost estimates for service delivery\u2014Estimation file. WHO; 2011."},{"key":"ref32","unstructured":"Banco de la Republica de Colombia. \u00cdndice de precios al consumidor (IPC). In: 1.3.2 Por grupo de gasto\u2014Serie hist\u00f3rica para un rango de fechas dado. 2015."},{"key":"ref33","unstructured":"Banco de la Republica de Colombia. \u00cdndice de precios al consumidor (IPC) -1.3.2. Por grupo de gasto [Internet]. Jan 2016 [cited 18 Jan 2016]. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/obiee.banrep.gov.co\/analytics\/saw.dll?Go&_scid=upQ1qTqIFxk\" xlink:type=\"simple\">http:\/\/obiee.banrep.gov.co\/analytics\/saw.dll?Go&amp;_scid=upQ1qTqIFxk<\/ext-link>"},{"key":"ref34","unstructured":"GDP per capita (current US$). In: The World Bank IBRD IDA. 2015."},{"key":"ref35","unstructured":"Banco de la Republica de Colombia. Salario m\u00ednimo legal en Colombia [Internet]. Jan 2016 [cited 18 Jan 2015]. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/obiee.banrep.gov.co\/analytics\/saw.dll?Go&Path=\/shared\/Consulta%20Series%20Estadisticas%20desde%20Excel\/1.%20Salarios\/1.1%20Salario%20minimo%20legal%20en%20Colombia\/1.1.1%20Serie%20historica&Options=rdf&NQUser=salarios&NQPassword=salarios&lang=es\" xlink:type=\"simple\">http:\/\/obiee.banrep.gov.co\/analytics\/saw.dll?Go&amp;Path=\/shared\/Consulta%20Series%20Estadisticas%20desde%20Excel\/1.%20Salarios\/1.1%20Salario%20minimo%20legal%20en%20Colombia\/1.1.1%20Serie%20historica&amp;Options=rdf&amp;NQUser=salarios&amp;NQPassword=salarios&amp;lang=es<\/ext-link>"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1111\/j.1365-3156.2007.01962.x","article-title":"Short communication: The cost-effectiveness of cutaneous leishmaniasis patient management during an epidemic in Chaparral, Colombia in 2004","volume":"12","author":"JC Vega","year":"2007","journal-title":"Trop Med Int Heal"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1111\/j.1365-3156.2005.01460.x","article-title":"Control of mucocutaneous leishmaniasis, a neglected disease: Results of a control programme in Satipo Province, Peru","volume":"10","author":"JP Guthmann","year":"2005","journal-title":"Trop Med Int Heal"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"466","DOI":"10.4269\/ajtmh.2001.65.466","article-title":"Randomized, controlled, double-blind trial of topical treatment of cutaneous leishmaniasis with paromomycin plus methylbenzethonium chloride ointment in Guatemala","volume":"65","author":"BA Arana","year":"2001","journal-title":"Am J Trop Med Hyg"},{"key":"ref39","article-title":"An\u00e1lisis de Costo-Efectividad de los tratamientos incluidos en la Gu\u00eda de Atenci\u00f3n Integral del Ministerio de Protecci\u00f3n Social de 2010 en pacientes adultos con Leishmaniasis Cut\u00e1nea y Mucocut\u00e1nea en Colombia [Internet]","author":"CP Ni\u00f1o Cuervo","year":"2014","journal-title":"Universidad Nacional de Colombia"},{"key":"ref40","unstructured":"SISMED [Internet]. 2013 [cited 2 Sep 2014]. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.sispro.gov.co\/recursosapp\/app\/Pages\/SISMED.aspx\" xlink:type=\"simple\">http:\/\/www.sispro.gov.co\/recursosapp\/app\/Pages\/SISMED.aspx<\/ext-link>"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1002\/hpm.930","article-title":"Orphan drug legislation: Lessons for neglected tropical diseases","volume":"24","author":"S Villa","year":"2009","journal-title":"Int J Health Plann Manage"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1046\/j.1365-3156.2001.00803.x","article-title":"Drugs for neglected diseases: A failure of the market and a public health failure?","volume":"6","author":"P Trouiller","year":"2001","journal-title":"Trop Med Int Heal"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1016\/S0140-6736(09)60233-6","article-title":"Rescuing the bottom billion through control of neglected tropical diseases","volume":"373","author":"PJ Hotez","year":"2009","journal-title":"Lancet"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.pt.2006.06.004","article-title":"Reconsidering the underestimated burden caused by neglected tropical diseases","volume":"22","author":"D Engels","year":"2006","journal-title":"Trends Parasitol"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"e2865","DOI":"10.1371\/journal.pntd.0002865","article-title":"The Global Burden of Disease Study 2010: Interpretation and Implications for the Neglected Tropical Diseases","volume":"8","author":"PJ Hotez","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"key":"ref46","article-title":"Global burden of skin disease as reflected in cochrane database of systematic reviews","author":"C Karimkhani","year":"2014","journal-title":"JAMA Dermatology"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"e313","DOI":"10.1371\/journal.pntd.0000313","article-title":"Complexities of assessing the disease burden attributable to leishmaniasis [Internet]","author":"C Bern","year":"2008","journal-title":"PLoS Neglected Tropical Diseases"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"e114","DOI":"10.1371\/journal.pntd.0000114","article-title":"Measuring the burden of neglected tropical diseases: The global burden of disease framework [Internet]","author":"CD Mathers","year":"2007","journal-title":"PLoS Neglected Tropical Diseases"},{"key":"ref49","unstructured":"Pan American Health Organization. Leishmaniases: Epidemiological Report of the Americas [Internet]. Washington, D.C.; 2014 Jun. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.paho.org\/hq\/index.php?option=com_topics&view=article&id=29&Itemid=40754&lang=en\" xlink:type=\"simple\">http:\/\/www.paho.org\/hq\/index.php?option=com_topics&amp;view=article&amp;id=29&amp;Itemid=40754&amp;lang=en<\/ext-link>"},{"key":"ref50","article-title":"Designing and Conducting Cost-Effectiveness Analyses in Medicine and Health Care","author":"P Muennig","year":"2002"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1111\/tmi.12025","article-title":"Adherence to miltefosine treatment for visceral leishmaniasis under routine conditions in Nepal","volume":"18","author":"S Uranw","year":"2013","journal-title":"Trop Med Int Heal"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1086\/519690","article-title":"Phase 4 trial of miltefosine for the treatment of Indian visceral leishmaniasis","volume":"196","author":"SK Bhattacharya","year":"2007","journal-title":"J Infect Dis"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/S0065-308X(05)61006-8","article-title":"Chemotherapy in the Treatment and Control of Leishmaniasis","author":"J Alvar","year":"2006","journal-title":"Advances in Parasitology"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"e2871","DOI":"10.1371\/journal.pntd.0002871","article-title":"Miltefosine and Antimonial Drug Susceptibility of Leishmania Viannia Species and Populations in Regions of High Transmission in Colombia","volume":"8","author":"OL Fern\u00e1ndez","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"issue":"Suppl 1","key":"ref55","first-page":"131","article-title":"Leishmania panamensis transmission in the domestic environment: the results of a prospective epidemiological survey in Santander, Colombia","volume":"26","author":"G Mu\u00f1oz","year":"2006","journal-title":"Biomedica"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1086\/383321","article-title":"Miltefosine for new world cutaneous leishmaniasis","volume":"38","author":"J Soto","year":"2004","journal-title":"Clin Infect Dis"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"210","DOI":"10.4269\/ajtmh.2008.78.210","article-title":"Short report: Efficacy of miltefosine for Bolivian cutaneous leishmaniasis","volume":"78","author":"J Soto","year":"2008","journal-title":"Am J Trop Med Hyg. American Society of Tropical Medicine and Hygiene"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1128\/AAC.01023-13","article-title":"Treatment failure and miltefosine susceptibility in dermal leishmaniasis caused by leishmania subgenus viannia species","volume":"58","author":"R Obonaga","year":"2014","journal-title":"Antimicrob Agents Chemother. American Society for Microbiology (ASM)"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1093\/infdis\/jiu039","article-title":"Failure of miltefosine in visceral leishmaniasis is associated with low drug exposure","volume":"210","author":"TPC Dorlo","year":"2014","journal-title":"J Infect Dis"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"e100220","DOI":"10.1371\/journal.pone.0100220","article-title":"Failure of miltefosine treatment for visceral leishmaniasis in children and men in South-East Asia","volume":"9","author":"B Ostyn","year":"2014","journal-title":"PLoS One. Public Library of Science"}],"updated-by":[{"DOI":"10.1371\/journal.pntd.0005459","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2017,4,25]],"date-time":"2017-04-25T00:00:00Z","timestamp":1493078400000}}],"container-title":["PLOS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pntd.0005459","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,23]],"date-time":"2024-06-23T13:12:32Z","timestamp":1719148352000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0005459"}},"subtitle":[],"editor":[{"given":"Marleen","family":"Boelaert","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2017,4,6]]},"references-count":60,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2017,4,6]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0005459","relation":{"new_version":[{"id-type":"doi","id":"10.1371\/journal.pntd.0005459","asserted-by":"object"}]},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,6]]}}}